hVIVO plc (LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that it will release its audited final results for the twelve months ended 31 December 2022 on Tuesday 25 April 2023.

hVIVO launches hMPV Challenge Model to fast-track treatments
hVIVO introduces groundbreaking hMPV challenge model to hasten vaccine and therapy development against respiratory pathogen. Learn more here.